Researcher’s Profile

Selim M. Arcasoy, MD

Americas Top Doctor : 

Advanced lung disease and lung transplantation

Arcasoy SM.Selection of patients with cystic fibrosis for lung transplantation.In: Braunwald E,Fauci AS,Isselbacher KJ,Kasper DL,Hauser SL,Longo DL,Jameson JL (Eds.) HarrisonsOnline.2007.Lederer DJ,Caplan-Shaw CE,O'Shea MK,Wilt JS,Basner RC,Bartels MN,Sonett JR,Arcasoy SM,Kawut SM.Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis.Am J Transplant 2006;6(2):398-403.Lederer DJ,Arcasoy SM,Wilt JS,D'Ovidio F,Sonett JR,Kawut SM.Six-minute Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis.Am J Respir Crit Care Med 2006;174:659-64.Lederer DJ,Arcasoy SM,Barr RG,Wilt JS,Bagiella E,D'Ovidio F,Sonett JR,Kawut SM.Racial and Ethnic Disparities in Idiopathic Pulmonary Fibrosis: A UNOS/OPTN Database Analysis.Am J Transplant 2006;6:2436-42.Caplan-Shaw CE,Arcasoy SM,Shane E,Lederer DJ,Wilt JS,O'Shea MK,Addesso V,Sonett JR,Kawut SM.Osteoporosis in diffuse parenchymal lung disease.Chest 2006 Jan;129(1):140-6.Erratum in: Chest 2006 Mar;129(3):831.Yip NH,Lederer DJ,Kawut SM,Wilt JS,D'Ovidio F,Wang Y,Dwyer E,Sonett JR,Arcasoy SM.Immunoglobulin G levels before and after lung transplantation.Am J Respir Crit Care Med 2006 Apr 15;173(8):917-21.Arcasoy SM,Wilt J.Medical complications after lung transplantation.Sem Respir Crit Care Med 2006;27:508-20.Orens JB,Estenne M,Arcasoy SM,Conte JV,Corris P,Egan JJ,Egan T,Keshvajee S,Knoop C,Kotloff R,Martinez FJ,Nathan S,Palmer S,Patterson A,Singer L,Snell G,Studer S,Vachiery JL,Glanville AR.International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update.J Heart Lung Transplant 2006;25:745-55.Lederer DJ,Kawut SM,Sonett JR,Vakiani E,Seward SL Jr,White JG,Wilt JS,Marboe CC,Gahl WA,Arcasoy SM.Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome.J Heart Lung Transplant 2005 Oct;24(10):1697-9.Arcasoy SM,Fisher A,Hachem RR,Scavuzzo M,Ware LB; ISHLT Working Group on Primary Lung Graft Dysfunction.Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomes.J Heart Lung Transplant 2005 Oct;24(10):1483-8.Kawut SM,Shah L,Wilt JS,Dwyer E,Maani PA,Daly TM,O'Shea MK,Sonett JR,Arcasoy SM.Risk factors and outcomes of hypogammaglobulinemia after lung transplantation.Transplantation 2005 Jun 27;79(12):1723-6.Kawut SM,O'Shea MK,Bartels MN,Wilt JS,Sonett JR,Arcasoy SM.Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation.Respir Med 2005 Nov;99(11):1431-9. Christie JD,Van Raemdonck D,de Perrot M,Barr M,Keshavjee S,Arcasoy SM,Orens J.Report of the ISHLT Working Group on Primary Lung Graft Dysfunction: Part I: Introduction and Methods.J Heart Lung Transplant 2005;24:1451-3.Arcasoy SM,J.D.Christie,V.A.Ferrari,M.St.John Sutton,D.A.Zisman,N.P.Blumenthal,A.Pochettino,R.M.Kotloff.Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease.Am J Respir Crit Care Med 2003;167:735-40.Arcasoy SM,Vachani A.Local and systemic thrombolytic therapy for acute venous thromboembolism.Clinics in Chest Medicine 2003;24:73-91.Arcasoy SM,G.Tino.Clinical Aspects of Obstructive Lung Disease.Seminars in Roentgenology 36:6-11,2001.Arcasoy SM,J.D.Christie,A.Pochettino,B.R.Rosengard,N.P.Blumenthal,J.E.Bavaria,R.M.Kotloff.Characteristics and Outcomes of Patients with Sarcoidosis Listed for Lung Transplantation.Chest 2001;120:873-80.Arcasoy SM,C.Hersh,J.D.Christie,D.Zisman,A.Pochettino,B.R.Rosengard,N.P.Blumenthal,H.I.Palevsky,J.E.Bavaria,R.M.Kotloff.Bronchogenic carcinoma Complicating Lung Transplantation.J Heart Lung Transplant 2001;20:1044-53.Arcasoy SM,R.M.Kotloff.Lung transplantation.N Engl J Med 340:1081-91,1999.

Dr. Arcasoy was recruited to Columbia University as the Medical Program Director of Lung Transplantation in 2001 from the University of Pennsylvania, where he was a key member of the Advanced Lung Disease and Lung Transplantation Program in the Division of Pulmonary and Critical Care Medicine. Since his recruitment, he completely turned around the Lung Transplantation Program to rank amongst the top ten programs in the country with regards to volume and top 1 to 3 programs in terms of patient survival. In addition to his position as the Medical Program Director of the Lung Transplant Program, he is the Director of the Interstitial Lung Disease Program at Columbia University.

Dr. Arcasoy has gained national and international reputation with various leadership roles in many professional organizations and scientific societies, including chairing the Thoracic Organ Transplant Committee of the American Society of Transplantation and the Transplant Network Steering Committee of the American College of Chest Physicians. He also serves as a reviewer for many scientific journals. Dr. Arcasoy has been named in America's Top Doctors in the past eight consecutive years and Top Doctors: New York Metro Area between 2002 and 2006.